CVS Health Reports Mixed Q2 Earnings, Lowers 2024 Outlook, Reshuffles Segment Management

Category: Finance

CVS Health Corp's stock fell after mixed Q2 earnings and a cut in annual profit guidance. Q2 sales were $91.23 billion, missing expectations. Adjusted EPS decreased to $1.83, while revenues in the Health Care Benefits segment rose 21.4%. Leadership changes were announced, with CEO Karen Lynch taking direct control of the Health Care Benefits segment. The company revised its EPS guidance to $6.40-$6.65 and cash flow guidance to approximately $9.0 billion, reflecting ongoing pressures in the Health Care Benefits segment.

Keywords: CVS Health, stock market, earnings report

Source: Yahoo Finance

Update At: 8/8/2024

Related Sources